The Germany Pharmaceutical CDMO Market growth continues to accelerate as cell and gene therapy manufacturing emerges as the next frontier requiring unprecedented specialized capabilities. With chimeric antigen receptor T-cell therapies, gene replacement therapies, and CRISPR-based treatments gaining regulatory approvals and entering commercial production, the demand for German CDMOs with viral...